Lars Valeur Køber

Lars Valeur Køber

Clinical Professor

Member of:

  • Internal medicine: Cardiology


Publication year:
All
11 - 18 out of 18Page size: 10
  1. 2003
  2. Published

    Prognostic importance of systolic and diastolic function after acute myocardial infarction

    Møller, J. E., Egstrup, K., Køber, Lars Valeur, Poulsen, S. H., Nyvad, O. & Torp-Pedersen, Christian, 2003, In: American Heart Journal. 145, 1, p. 147-53 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Survival after withdrawal of dofetilide in patients with congestive heart failure and a short baseline QTc interval; a follow-up on the Diamond-CHF QT substudy

    Brendorp, B., Torp-Pedersen, Christian, Elming, H. & Køber, Lars Valeur, 2003, In: European Heart Journal. 24, 3, p. 274-9 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects

    Ihlemann, N., Rask-Madsen, C., Perner, Anders, Dominguez, Helena, Hermann, T., Køber, Lars Valeur & Torp-Pedersen, Christian, 2003, In: American Journal of Physiology: Heart and Circulatory Physiology. 285, 2, p. H875-82

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function

    Abdulla, J., Burchardt, H., Z Abildstrøm, S., Køber, Lars Valeur, Torp-Pedersen, Christian & TRACE Study Group, T. S. G., 2003, In: European Heart Journal. 24, 23, p. 2116-22 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The prognostic value of QTc interval and QT dispersion following myocardial infarction in patients treated with or without dofetilide

    Brendorp, B., Elming, H., Jun, L., Køber, Lars Valeur, Torp-Pedersen, Christian & DIAMOND Study Group, D. S. G., 2003, In: Clinical Cardiology. 26, 5, p. 219-25 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans

    Rask-Madsen, C., Dominguez, Helena, Ihlemann, N., Hermann, T., Køber, Lars Valeur & Torp-Pedersen, Christian, 2003, In: Circulation. 108, 15, p. 1815-21 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context

    Velazquez, E. J., Pfeffer, M. A., McMurray, J. V., Maggioni, A. P., Rouleau, J. L., Van de Werf, F., Køber, Lars Valeur, White, H. D., Swedberg, K., Leimberger, J. D., Gallo, P., Sellers, M. A., Edwards, S., Henis, M., Califf, R. M. & VALIANT Investigators, V. I., 2003, In: European Journal of Heart Failure. 5, 4, p. 537-44 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

    Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J., Køber, Lars Valeur, Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., Leimberger, J. D., Henis, M., Edwards, S., Zelenkofske, S., Sellers, M. A., Califf, R. M. & Valsartan in Acute Myocardial Infarction Trial Investigators, V. I. A. M. I. T. I., 2003, In: New England Journal of Medicine. 349, 20, p. 1893-906 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 543423